The DOI matches its Crossref record; 227 of the 230 references it cites were found in a registry or an index.
Rho guanine nucleotide exchange factors: regulators of Rho GTPase activity in development and disease
Open accessAbstract
The aberrant activity of Ras homologous (Rho) family small GTPases (20 human members) has been implicated in cancer and other human diseases. However, in contrast to the direct mutational activation of Ras found in cancer and developmental disorders, Rho GTPases are activated most commonly in disease by indirect mechanisms. One prevalent mechanism involves aberrant Rho activation via the deregulated expression and/or activity of Rho family guanine nucleotide exchange factors (RhoGEFs). RhoGEFs promote formation of the active GTP-bound state of Rho GTPases. The largest family of RhoGEFs is comprised of the Dbl family RhoGEFs with 70 human members. The multitude of RhoGEFs that activate a single Rho GTPase reflects the very specific role of each RhoGEF in controlling distinct signaling mechanisms involved in Rho activation. In this review, we summarize the role of Dbl RhoGEFs in development and disease, with a focus on Ect2 (epithelial cell transforming squence 2), Tiam1 (T-cell lymphoma invasion and metastasis 1), Vav and P-Rex1/2 (PtdIns(3,4,5)P3 (phosphatidylinositol (3,4,5)-triphosphate)-dependent Rac exchanger).
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“DH GEFs constitute the larger of the two classes, with over 70 members (30, 31).”
From RHO to the DOCK for GDP disembarking: Structural insights into the DOCK GTPase nucleotide exchange factors (2021) · cites this paper as [30]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Spindler, M. J., Burmeister, B. T., Huang, Y., Hsiao, E. C., Salomonis, N., Scott, M. J., Srivastava, D., Carnegie, G. K., & Conklin, B. R. (2013) · PLoS ONE · doi:10.1371/journal.pone.0062705 · Cited by 13
RetractedClustal W and Clustal X version 2.0
Larkin, M., Blackshields, G., Brown, N. P., Chenna, R., McGettigan, P., McWilliam, H., Valentin, F., Wallace, I. M., Wilm, A., López, R., et al. (2007) · Bioinformatics · doi:10.1093/bioinformatics/btm404 · Cited by 28,598
The Consensus Coding Sequences of Human Breast and Colorectal Cancers
Sjöblom, T., Jones, S., Wood, L. D., Parsons, D. W., Lin, J., Barber, T. D., Mandelker, D. L., Leary, R. J., Ptak, J., Silliman, N., et al. (2006) · Science · doi:10.1126/science.1133427 · Cited by 3,161
RHO GTPASES: Biochemistry and Biology
Jaffe, A. B., & Hall, A. (2005) · Annual Review of Cell and Developmental Biology · doi:10.1146/annurev.cellbio.21.020604.150721 · Cited by 3,009
A landscape of driver mutations in melanoma
Hodis, E., Watson, I. R., Kryukov, G. V., Arold, S. T., Imielinski, M., Theurillat, J.-P., Nickerson, E., Auclair, D., Li, L., Place, C., et al. (2012) · Cell · doi:10.1016/j.cell.2012.06.024 · Cited by 2,610
Rho GTPases and their effector proteins
Bishop, A. L., & Hall, A. (2000) · Biochemical Journal · doi:10.1042/bj3480241 · Cited by 2,019
GEF means go: turning on RHO GTPases with guanine nucleotide-exchange factors
Rossman, K. L., Der, C. J., & Sondek, J. (2005) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm1587 · Cited by 1,697
Self-citationSahai, E., & Marshall, C. (2002) · Nature Reviews. Cancer · doi:10.1038/nrc725 · Cited by 1,575
The Ras superfamily at a glance
Wennerberg, K., Rossman, K. L., & Der, C. J. (2005) · Journal of Cell Science · doi:10.1242/jcs.01660 · Cited by 1,549
Self-citationRas oncogenes: split personalities
Karnoub, A. E., & Weinberg, R. A. (2008) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2438 · Cited by 1,467
Flagged first, then by citations
3 of the 230 references couldn’t be matched to a known paper.
Cited by
Sorted by citations
Items 101–200 of 378
Dynamics of hydraulic and contractile wave-mediated fluid transport during Drosophila oogenesis
Alsous, J. I., Romeo, N., Jackson, J. A., Mason, F. M., Dunkel, J., & Martin, A. C. (2021) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2019749118 · Cited by 35
Hernández-Vásquez, M. N., Adame-Garcia, S. R., Hamoud, N., Chidiac, R., Reyes‐Cruz, G., Gratton, J., Côté, J., & Vázquez‐Prado, J. (2017) · Journal of Biological Chemistry · doi:10.1074/jbc.m117.780304 · Cited by 34
Rac1 is a downstream effector of PKCα in structural synaptic plasticity
Tu, X., Yasuda, R., & Colgan, L. A. (2020) · Scientific Reports · doi:10.1038/s41598-020-58610-6 · Cited by 31
Molecular subversion of Cdc42 signalling in cancer
Murphy, N. P., Mokhtar, A. M. B. A., Mott, H. R., & Owen, D. (2021) · Biochemical Society Transactions · doi:10.1042/bst20200557 · Cited by 34
Regulation of NADPH Oxidases by G Protein-Coupled Receptors
Petry, A., & Görlach, A. (2018) · Antioxidants and Redox Signaling · doi:10.1089/ars.2018.7525 · Cited by 34
Paskus, J. D., Tian, C., Fingleton, E., Shen, C., Chen, X., Li, Y., Myers, S. A., Badger, J. D., Bemben, M. A., Herring, B. E., et al. (2019) · Cell Reports · doi:10.1016/j.celrep.2019.10.115 · Cited by 31
A Nonpump Function of Sodium Iodide Symporter in Thyroid Cancer via Cross-talk with PTEN Signaling
Fěng, F., Yehia, L., Ni, Y., Chang, Y. S., Jhiang, S. M., & Eng, C. (2018) · Cancer Research · doi:10.1158/0008-5472.can-18-1954 · Cited by 32
The crystal structure of the RhoA–AKAP-Lbc DH–PH domain complex
Azeez, K. R. A., Knapp, S., Fernandes, J. M. P., Klußmann, E., & Elkins, J. M. (2014) · Biochemical Journal · doi:10.1042/bj20140606 · Cited by 31
Choudhari, R., Minero, V. G., Menotti, M., Pulito, R., Brakebusch, C., Compagno, M., Voena, C., Ambrogio, C., & Chiarle, R. (2016) · Blood · doi:10.1182/blood-2015-11-683052 · Cited by 31
Acevedo-Diaz, A., Ortíz-Soto, G., Suárez-Arroyo, I. J., Zayas‐Santiago, A., & Martínez, M. (2019) · Nutrients · doi:10.3390/nu11051116 · Cited by 31
Žúbor, P., Daňková, Z., Kolková, Z., Holubeková, V., Braný, D., Meršaková, S., Samec, M., Líšková, A., Koklesová, L., Kubatka, P., et al. (2020) · Cancers · doi:10.3390/cancers12051292 · Cited by 32
Role of Small GTPase RhoA in DNA Damage Response
Cheng, C.-B., Seen, D. L. T., Zheng, C., Zeng, R., & Li, E. (2021) · Biomolecules · doi:10.3390/biom11020212 · Cited by 31
Rho GTPase signalling networks in cancer cell transendothelial migration
Rodenburg, W. S., & van Buul, J. D. (2021) · Vascular Biology · doi:10.1530/vb-21-0008 · Cited by 29
Molecular, Circuit, and Stress Response Characterization of Ventral Pallidum Npas1-Neurons
Morais‐Silva, G., Campbell, R. R., Nam, H., Basu, M., Pagliusi, M., Fox, M. E., Chan, C. S., Iñiguez, S. D., Ament, S. A., Cramer, N., et al. (2022) · Journal of Neuroscience · doi:10.1523/jneurosci.0971-22.2022 · Cited by 33
Pisamai, S., Roytrakul, S., Phaonakrop, N., Jaresitthikunchai, J., & Suriyaphol, G. (2018) · PLoS ONE · doi:10.1371/journal.pone.0200619 · Cited by 30
ECT2 associated to PRICKLE1 are poor-prognosis markers in triple-negative breast cancer
Daulat, A. M., Finetti, P., Revinski, D. R., Wagner, M. S., Camoin, L., Audebert, S., Birnbaum, D., Kodjabachian, L., Borg, J., & Bertucci, F. (2019) · British Journal of Cancer · doi:10.1038/s41416-019-0448-z · Cited by 29
Allgayer, H., Leupold, J. H., & Patil, N. (2019) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2019.07.018 · Cited by 29
Sun, Z., Zhang, H., Zhang, Y., Liao, L., Zhou, W., Zhang, F., Lian, F., Huang, J., Xu, P., Zhang, R., et al. (2020) · Advanced Science · doi:10.1002/advs.202000098 · Cited by 28
Huang, H., Fan, L., Zhan, R., Wu, S., & NIU, W. (2015) · Oncology Letters · doi:10.3892/ol.2015.3831 · Cited by 28
John, A. A., Prakash, R., Kureel, J., & Singh, D. R. (2018) · Journal of Molecular Medicine · doi:10.1007/s00109-018-1624-y · Cited by 28
Rho GTPases: Promising candidates for overcoming chemotherapeutic resistance
Zheng, C., Zeng, R., Xu, L., & Li, E. (2020) · Cancer Letters · doi:10.1016/j.canlet.2020.01.018 · Cited by 28
Rac-GEF/Rac Signaling and Metastatic Dissemination in Lung Cancer
Cooke, M., Baker, M. J., & Kazanietz, M. G. (2020) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2020.00118 · Cited by 28
Schmitz, H., Jendretzki, A., Wittland, J., Wiechert, J., & Heinisch, J. J. (2015) · Molecular Microbiology · doi:10.1111/mmi.12937 · Cited by 29
Vav1: A Dr. Jekyll and Mr. Hyde protein - good for the hematopoietic system, bad for cancer
Katzav, S. (2015) · Oncotarget · doi:10.18632/oncotarget.5086 · Cited by 29
Rho GTPases in mammalian spinal neural tube closure
Rolo, A., Escuin, S., Greene, N. D. E., & Copp, A. J. (2016) · Small GTPases · doi:10.1080/21541248.2016.1235388 · Cited by 27
Lovelace, M. D., Powter, E. E., Coleman, P. R., Zhao, Y., Parker, A. L., Chang, G., Lay, A. J., Hunter, J., McGrath, A. P., Jormakka, M., et al. (2017) · Molecular Biology of the Cell · doi:10.1091/mbc.e16-05-0285 · Cited by 26
Small GTPases in peroxisome dynamics
Just, W. W., & Peränen, J. (2016) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2016.01.004 · Cited by 25
The first DEP domain of the RhoGEF P-Rex1 autoinhibits activity and contributes to membrane binding
Ravala, S. K., Hopkins, J. B., Plescia, C. B., Allgood, S. R., Kane, M. A., Cash, J. N., Stahelin, R. V., & Tesmer, J. J. G. (2020) · Journal of Biological Chemistry · doi:10.1074/jbc.ra120.014534 · Cited by 25
The PKC universe keeps expanding: From cancer initiation to metastasis
Rahimova, N., Cooke, M., Zhang, S., Baker, M. J., & Kazanietz, M. G. (2020) · Advances in Biological Regulation · doi:10.1016/j.jbior.2020.100755 · Cited by 26
Kukimoto‐Niino, M., Ihara, K., Murayama, K., & Shirouzu, M. (2021) · Current Opinion in Structural Biology · doi:10.1016/j.sbi.2021.08.001 · Cited by 30
Increased expression of ECT2 predicts the poor prognosis of breast cancer patients
Yi, M., Zhang, D., Song, B., Zhao, B., Niu, M., Wu, Y., Dai, Z., & Wu, K. (2022) · Experimental Hematology and Oncology · doi:10.1186/s40164-022-00361-3 · Cited by 26
Autophagy suppresses cell migration by degrading GEF-H1, a RhoA GEF
Yoshida, T., Tsujioka, M., Honda, S., Tanaka, M., & Shimizu, S. (2016) · Oncotarget · doi:10.18632/oncotarget.8883 · Cited by 26
Zhou, H., Cai, L., Zhang, X., Li, A., Miao, Y., Li, Q., Qiu, X., & Wang, E. (2018) · Laboratory Investigation · doi:10.1038/s41374-018-0022-y · Cited by 26
A-Kinase Anchoring Protein 13 (AKAP13) Augments Progesterone Signaling in Uterine Fibroid Cells
Ng, S. S. M., Jorge, S., Malik, M., Britten, J., Su, S.-C., Armstrong, C. R., Brennan, J. T., Chang, S., Baig, K. M., Driggers, P. H., et al. (2018) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2018-01216 · Cited by 25
Design of novel lead molecules against RhoG protein as cancer target – a computational study
Dasari, T., Kondagari, B., Dulapalli, R., Abdelmonsef, A. H., Mukkera, T., Padmarao, L. S., Malkhed, V., & Vuruputuri, U. (2016) · Journal of Biomolecular Structure and Dynamics · doi:10.1080/07391102.2016.1244492 · Cited by 24
Tomino, T., Tajiri, H., Tatsuguchi, T., Shirai, T., Oisaki, K., Matsunaga, S., Sanematsu, F., Sakata, D., Yoshizumi, T., Maehara, Y., et al. (2018) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2018.02.073 · Cited by 24
Humphries, B. A., Wang, Z., & Yang, C. (2020) · Cancers · doi:10.3390/cancers12051092 · Cited by 26
Having an Old Friend for Dinner: The Interplay between Apoptotic Cells and Efferocytes
Lam, A. L., & Heit, B. (2021) · Cells · doi:10.3390/cells10051265 · Cited by 22
RAC1 Activation as a Potential Therapeutic Option in Metastatic Cutaneous Melanoma
Colón‐Bolea, P., García‐Gómez, R., & Casar, B. (2021) · Biomolecules · doi:10.3390/biom11111554 · Cited by 24
Molecular subversion of Cdc42 signalling in cancer.
Murphy, N. P., Mokhtar, A. M. A., Mott, H. R., & Owen, D. (2021) · Apollo (University of Cambridge) · doi:10.17863/cam.70501 · Cited by 24
Raimondi, F., Felline, A., & Fanelli, F. (2015) · Journal of Chemical Information and Modeling · doi:10.1021/acs.jcim.5b00122 · Cited by 24
PAR3-aPKC regulates Tiam1 by modulating suppressive internal interactions
Matsuzawa, K., Akita, H., Watanabe, T., Kakeno, M., Matsui, T., Wang, S., & Kaibuchi, K. (2016) · Molecular Biology of the Cell · doi:10.1091/mbc.e15-09-0670 · Cited by 24
Ulc, A., Gottschling, C., Schäfer, I., Wegrzyn, D., van Leeuwen, S., Luft, V., Reinhard, J., & Faissner, A. (2017) · Biological Chemistry · doi:10.1515/hsz-2016-0275 · Cited by 25
Rho Guanine Nucleotide Exchange Factor ARHGEF17 Is a Risk Gene for Intracranial Aneurysms
Yang, X., Li, J., Fang, Y., Zhang, Z., Jin, D., Chen, X., Zhao, Y. E., Li, M., Huan, L., Kent, T. A., et al. (2018) · Circulation Genomic and Precision Medicine · doi:10.1161/circgen.117.002099 · Cited by 25
Structure and function of the Fgd family of divergent FYVE domain proteins
Eitzen, G., Smithers, C. C., Murray, A. G., & Overduin, M. (2018) · Biochemistry and Cell Biology · doi:10.1139/bcb-2018-0185 · Cited by 24
Gαs directly drives PDZ-RhoGEF signaling to Cdc42
Castillo‐Kauil, A., García‐Jiménez, I., Cervantes‐Villagrana, R. D., Adame-Garcia, S. R., Beltrán‐Navarro, Y. M., Gutkind, J. S., Reyes‐Cruz, G., & Vázquez‐Prado, J. (2020) · Journal of Biological Chemistry · doi:10.1074/jbc.ac120.015204 · Cited by 23
TRIM56 acts through the IQGAP1-CDC42 signaling axis to promote glioma cell migration and invasion
Zhang, Q., Zheng, J., Wu, W., Lian, H., Iranzad, N., Wang, E., Yang, L., Wang, X., & Jiang, X. (2023) · Cell Death and Disease · doi:10.1038/s41419-023-05702-6 · Cited by 23
Development of Substrate‐Derived Sirtuin Inhibitors with Potential Anticancer Activity
Kuhlmann, N., Chollet, C., Baldus, L., Neundorf, I., & Lammers, M. (2017) · ChemMedChem · doi:10.1002/cmdc.201700414 · Cited by 22
The Rho GTPase signalling pathway in urothelial carcinoma
Woldu, S. L., Hutchinson, R. C., Krabbe, L., Şanlı, Ö., & Margulis, V. (2017) · Nature Reviews Urology · doi:10.1038/nrurol.2017.184 · Cited by 22
Thompson, A. P., Bitsina, C., Gray, J. L., von Delft, F., & Brennan, P. E. (2021) · Journal of Biological Chemistry · doi:10.1016/j.jbc.2021.100521 · Cited by 21
“DH GEFs constitute the larger of the two classes, with over 70 members (30, 31).”
BackgroundAn RNAi screen unravels the complexities of Rho GTPase networks in skin morphogenesis
Laurin, M., Gomez, N. C., Levorse, J. M., Sendoel, A., Sribour, M., & Fuchs, E. V. (2019) · eLife · doi:10.7554/elife.50226 · Cited by 20
Turning Platelets Off and On: Role of RhoGAPs and RhoGEFs in Platelet Activity
Comer, S. P. (2022) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2021.820945 · Cited by 19
RhoB as a tumor suppressor: It’s all about localization
Zaoui, K., & Duhamel, S. (2023) · European Journal of Cell Biology · doi:10.1016/j.ejcb.2023.151313 · Cited by 21
Defining functional interactions during biogenesis of epithelial junctions
Erasmus, J. C., Bruche, S., Pizarro, L., Maimari, N., Poggioli, T., Tomlinson, C. D., Lees, J. G., Zalivina, I., Wheeler, A. P., Alberts, A. S., et al. (2016) · Nature Communications · doi:10.1038/ncomms13542 · Cited by 21
Tang, J., Liu, C., Xu, B., Wang, D., Ma, Z., & Chang, X. (2018) · Experimental Cell Research · doi:10.1016/j.yexcr.2018.11.007 · Cited by 21
Fěng, F., Han, H., Wu, S., & Wang, H. (2021) · Frontiers in Oncology · doi:10.3389/fonc.2021.718578 · Cited by 20
The Role of Fast-Cycling Atypical RHO GTPases in Cancer
Aspenström, P. (2022) · Cancers · doi:10.3390/cancers14081961 · Cited by 21
The mechanobiology of NK cells- ‘Forcing NK to Sense’ target cells
Wong, D. C. P., & Ding, J. L. (2023) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2023.188860 · Cited by 20
Cervantes‐Villagrana, R. D., García‐Jiménez, I., & Vázquez‐Prado, J. (2023) · Cellular Signalling · doi:10.1016/j.cellsig.2023.110749 · Cited by 20
MiR‐490‐5p inhibits the stemness of hepatocellular carcinoma cells by targeting ECT2
Yu, Y., Cai, O., Wu, P., & Tan, S. (2018) · Journal of Cellular Biochemistry · doi:10.1002/jcb.27459 · Cited by 20
RAC1 induces nuclear alterations through the LINC complex to enhance melanoma invasiveness
Colón‐Bolea, P., García‐Gómez, R., Shackleton, S., Crespo, P., Bustelo, X. R., & Casar, B. (2020) · Molecular Biology of the Cell · doi:10.1091/mbc.e20-02-0127 · Cited by 20
Saadeldin, I. M., Tukur, H. A., Aljumaah, R. S., & Sindi, R. A. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2020.616762 · Cited by 20
The dynamic behavior of Ect2 in response to DNA damage
He, D. N., Xiang, J., Li, B., & Liu, H. (2016) · Scientific Reports · doi:10.1038/srep24504 · Cited by 20
PLEKHG4B enables actin cytoskeletal remodeling during epithelial cell–cell junction formation
Ninomiya, K., Ohta, K., Yamashita, K., Mizuno, K., & Ohashi, K. (2020) · Journal of Cell Science · doi:10.1242/jcs.249078 · Cited by 19
Xu, Z., Gakhar, L., Bain, F. E., Spies, M., & Fuentes, E. J. (2017) · Journal of Biological Chemistry · doi:10.1074/jbc.m117.799114 · Cited by 18
Fujiwara, S., Matsui, T. S., Ohashi, K., Deguchi, S., & Mizuno, K. (2018) · PLoS ONE · doi:10.1371/journal.pone.0195124 · Cited by 19
Bodman, J. A. R., Yang, Y., Logan, M. R., & Eitzen, G. (2015) · Journal of Biological Chemistry · doi:10.1074/jbc.m114.630764 · Cited by 19
Phosphorylation of Serine 402 Regulates RacGAP Protein Activity of FilGAP Protein
Morishita, Y., Tsutsumi, K., & Ohta, Y. (2015) · Journal of Biological Chemistry · doi:10.1074/jbc.m115.666875 · Cited by 21
Wyse, M. M., Goicoechea, S. M., García‐Mata, R., Nestor‐Kalinoski, A. L., & Eisenmann, K. M. (2017) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2017.01.087 · Cited by 18
Stretching Induces Overexpression of RhoA and Rac1 GTPases in Breast Cancer Cells
Yadav, S., Barton, M., & Nguyen, N. (2019) · Advanced Biosystems · doi:10.1002/adbi.201900222 · Cited by 18
A feedforward circuit shaped by ECT2 and USP7 contributes to breast carcinogenesis
Zhang, Q., Cao, C., Gong, W., Bao, K., Wang, Q., Wang, Y., Bi, L., Ma, S., Zhao, J., Liu, L., et al. (2020) · Theranostics · doi:10.7150/thno.46878 · Cited by 18
The actin-regulatory protein Hem-1 is essential for alveolar macrophage development
Suwankitwat, N., Libby, S., Liggitt, H. D., Avalos, A., Ruddell, A., Rosch, J. W., Park, H., & Iritani, B. M. (2021) · Journal of Experimental Medicine · doi:10.1084/jem.20200472 · Cited by 18
Vav1 mutations identified in human cancers give rise to different oncogenic phenotypes
Shalom, B., Farago, M., Pikarsky, E., & Katzav, S. (2018) · Oncogenesis · doi:10.1038/s41389-018-0091-1 · Cited by 19
Nuclear PKCι-ECT2-Rac1 and Ribosome Biogenesis: A Novel Axis in Lung Tumorigenesis
Baker, M. J., Cooke, M., & Kazanietz, M. G. (2017) · Cancer Cell · doi:10.1016/j.ccell.2017.01.008 · Cited by 17
Isozaki, Y., Sakai, K., Kohiro, K., kagoshima, K., Iwamura, Y., Sato, H., Rindner, D., Fujiwara, S., Yamashita, K., Mizuno, K., et al. (2020) · Molecular Biology of the Cell · doi:10.1091/mbc.e19-07-0357 · Cited by 17
P-REX1-Independent, Calcium-Dependent RAC1 Hyperactivation in Prostate Cancer
Baker, M. J., Abba, M. C., García‐Mata, R., & Kazanietz, M. G. (2020) · Cancers · doi:10.3390/cancers12020480 · Cited by 17
The molecular basis for immune dysregulation by the hyperactivated E62K mutant of the GTPase RAC2
Arrington, M. E., Temple, B. R. S., Schaefer, A., & Campbell, S. L. (2020) · Journal of Biological Chemistry · doi:10.1074/jbc.ra120.012915 · Cited by 18
β-Pix-dependent cellular protrusions propel collective mesoderm migration in the mouse embryo
Omelchenko, T., Hall, A., & Anderson, K. V. (2020) · Nature Communications · doi:10.1038/s41467-020-19889-1 · Cited by 19
Braga, V. M. M. (2017) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a028746 · Cited by 18
Ru, F.-X., Kong, F., Ren, C., He, Y.-S., Xia, S.-Y., Yu-ning, L., Liang, Y., Feng, J.-J., Wei, Z.-Y., & Chen, J. (2022) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2022.896794 · Cited by 16
Kim, K., Kim, D.-W., Kim, Y., Tang, J., Kirk, N., Gan, Y., Kim, B.-J., Fang, B., Park, J., Zheng, Y., et al. (2022) · Cancer Research · doi:10.1158/0008-5472.can-22-1170 · Cited by 16
Kuniyoshi, M. L. G., da Silva‐Gomes, R. N., Vieira, J. C. S., Hessel, M. C., Mareco, E. A., dos Santos, V. B., Carvalho, R. F., Padilha, P. D. M., & Dal‐Pai‐Silva, M. (2019) · Comparative Biochemistry and Physiology Part D Genomics and Proteomics · doi:10.1016/j.cbd.2019.04.005 · Cited by 16
Interconnecting Flexibility, Structural Communication, and Function in RhoGEF Oncoproteins
Felline, A., Belmonte, L., Raimondi, F., Bellucci, L., & Fanelli, F. (2019) · Journal of Chemical Information and Modeling · doi:10.1021/acs.jcim.9b00271 · Cited by 16
Deák, V. A., & Klußmann, E. (2016) · Current Drug Targets · doi:10.2174/1389450116666150416114247 · Cited by 16
Janus-faces of NME–oncoprotein interactions
Vlatković, N., Chang, S.-H., & Boyd, M. T. (2014) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/s00210-014-1062-5 · Cited by 15
Fujiwara, S., Matsui, T. S., Ohashi, K., Mizuno, K., & Deguchi, S. (2019) · Genes to Cells · doi:10.1111/gtc.12682 · Cited by 15
Goka, E. T., Chaturvedi, P., Lopez, D. T. M., & Lippman, M. E. (2020) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-19-0762 · Cited by 17
Arhgef12 drives IL17A-induced airway contractility and airway hyperresponsiveness in mice
Fong, V., Hsu, A., Wu, E. E., Looney, A. P., Ganesan, P., Ren, X., Sheppard, D., Wicher, S. A., Thompson, M. A., Britt, R. D., et al. (2018) · JCI Insight · doi:10.1172/jci.insight.123578 · Cited by 15
Sun, C., Liu, C., Li, S., Li, H., Wang, Y., Xie, Y., Li, B., Cui, X., Chen, Y., Zhang, W., et al. (2014) · Europe PMC (PubMed Central) · Cited by 14
A pull-down procedure for the identification of unknown GEFs for small GTPases
Koch, D., Rai, A., Ali, I., Bleimling, N., Friese, T., Brockmeyer, A., Janning, P., Goud, B., Itzen, A., Müller, M. P., et al. (2016) · Small GTPases · doi:10.1080/21541248.2016.1156803 · Cited by 14
Fgd5 is a Rac1-specific Rho GEF that is selectively inhibited by aurintricarboxylic acid
Park, S., Guo, Y., Negre, J., Preto, J., Smithers, C. C., Azad, A. K., Overduin, M., Murray, A. G., & Eitzen, G. (2019) · Small GTPases · doi:10.1080/21541248.2019.1674765 · Cited by 14
García‐Jiménez, I., Cervantes‐Villagrana, R. D., del-Río-Robles, J. E., Castillo‐Kauil, A., Beltrán‐Navarro, Y. M., García-Román, J., Reyes‐Cruz, G., & Vázquez‐Prado, J. (2021) · Journal of Biological Chemistry · doi:10.1016/j.jbc.2021.101440 · Cited by 14
Rho GTPases: Non‐canonical regulation by cysteine oxidation
Hurst, M., McGarry, D. J., & Olson, M. F. (2021) · BioEssays · doi:10.1002/bies.202100152 · Cited by 15
Jha, P., Singh, P., Arora, S., Sultan, A., Nayek, A., Ponnusamy, K., Syed, M. A., Dohare, R., & Chopra, M. (2022) · Journal of Cellular Biochemistry · doi:10.1002/jcb.30213 · Cited by 14
A Gα12-specific Binding Domain in AKAP-Lbc and p114RhoGEF
Martin, J. W., Cavagnini, K. S., Brawley, D. N., Berkley, C. Y., Smolski, W. C., Garcia, R. D., Towne, A. L., Sims, J. R., & Meigs, T. E. (2016) · Journal of Molecular Signaling · doi:10.5334/1750-2187-11-3 · Cited by 14
Liu, X., Zhang, J., Ju, S., Liu, L., Sun, Y., Guo, L., Zhen, Q., Han, S., Lü, W., & Zhang, Y. (2022) · Cancer Gene Therapy · doi:10.1038/s41417-022-00525-7 · Cited by 13
Activation Mechanism of RhoA Caused by Constitutively Activating Mutations G14V and Q63L
Chen, S., Zhang, Z., Zhang, Y., Choi, T., & Zhao, Y. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms232415458 · Cited by 13
You, J., Kim, Y., Lee, S., Bashir, R., & Chen, J. (2023) · Journal of Cachexia Sarcopenia and Muscle · doi:10.1002/jcsm.13278 · Cited by 12
A ‘synthetic-sickness’ screen for senescence re-engagement targets in mutant cancer backgrounds
Cairney, C. J., Godwin, L. S., Bilsland, A. E., Burns, S., Stevenson, K. H., McGarry, L., Revie, J., Moore, J. D., Wiggins, C. M., Collinson, R. S., et al. (2017) · PLoS Genetics · doi:10.1371/journal.pgen.1006942 · Cited by 13
Gai, Z., & Zhao, J. (2019) · Genomics · doi:10.1016/j.ygeno.2019.09.013 · Cited by 13
Metadata
- Authors
- Cook, D. R., Rossman, K. L., & Der, C. J.
- Affiliations
- University of North Carolina at Chapel Hill (US)
- Corresponding author
- Der, C J
- ORCID
- Venue
- Oncogene
- Published
- 2013-09-16
- Volume
- 33
- Issue
- 31
- Pages
- 4021-4035
- ISSN
- 0950-9232 (ISSN-L)
- 1476-5594
- PMC
- PMC4875565
- OpenAlex
- W2024222958
- Cited by
- 378
- References
- 230
- Citations by year
- 2026: 14 · 2025: 15 · 2024: 17 · 2023: 26 · 2022: 35 · 2021: 45 · 2020: 43 · 2019: 33 · 2018: 37 · 2017: 29 · 2016: 34 · 2015: 24 · 2014: 23 · 2013: 3
- FWCI
- 2.64
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Oncogene (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- Carolina Digital Repository (University of North Carolina at Chapel Hill) (submittedVersion)
- UNC Libraries
- Funders
- Pancreatic Cancer Action Network
- National Institutes of Health (5r01ca042978-30)
- National Cancer Institute (CA159821, CA 71341, R01-CA042978, F31CA159821, T32CA071341)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Protein Kinase Regulation and GTPase Signaling
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Cellular transport and secretion
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Hippo pathway signaling and YAP/TAZ
- Keywords
- RhoGEF, Rho GTPases, ECT2, Tiam1, Vav, Rho activation, cancer, developmental disorders, phosphatidylinositol 3,4,5-trisphosphate, small GTPase signaling
- MeSH terms
- Congenital Abnormalities, Animals, Cell Division, Humans, Neoplasms, Gene Expression Regulation, Neoplastic, rho GTP-Binding Proteins, Genetic Diseases, Inborn, Proto-Oncogene Proteins c-vav, Rho Guanine Nucleotide Exchange Factors
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review